You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Sanofi buys Principia Biopharma

Sanofi has announced its intent to buy US group Principia Biopharma, a late-stage group focused on developing treatments for immune-mediated diseases.